DE69328438D1 - Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung - Google Patents

Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung

Info

Publication number
DE69328438D1
DE69328438D1 DE69328438T DE69328438T DE69328438D1 DE 69328438 D1 DE69328438 D1 DE 69328438D1 DE 69328438 T DE69328438 T DE 69328438T DE 69328438 T DE69328438 T DE 69328438T DE 69328438 D1 DE69328438 D1 DE 69328438D1
Authority
DE
Germany
Prior art keywords
oak bark
bark extract
ions
extract
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69328438T
Other languages
English (en)
Other versions
DE69328438T2 (de
Inventor
N Hon
Thomas Stanley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greystone Medical Group Inc
Original Assignee
Greystone Medical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greystone Medical Group Inc filed Critical Greystone Medical Group Inc
Publication of DE69328438D1 publication Critical patent/DE69328438D1/de
Application granted granted Critical
Publication of DE69328438T2 publication Critical patent/DE69328438T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Laminated Bodies (AREA)
  • Road Paving Structures (AREA)
  • Cosmetics (AREA)
DE69328438T 1992-11-06 1993-11-04 Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung Expired - Lifetime DE69328438T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97307192A 1992-11-06 1992-11-06
PCT/US1993/010670 WO1994011010A2 (en) 1992-11-06 1993-11-04 Compositions of oak bark extract, related synthetic compositions, and method of using same

Publications (2)

Publication Number Publication Date
DE69328438D1 true DE69328438D1 (de) 2000-05-25
DE69328438T2 DE69328438T2 (de) 2001-01-04

Family

ID=25520460

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69328438T Expired - Lifetime DE69328438T2 (de) 1992-11-06 1993-11-04 Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung

Country Status (21)

Country Link
US (1) US6149947A (de)
EP (1) EP0668769B1 (de)
JP (1) JP3640215B2 (de)
AT (1) ATE191850T1 (de)
AU (1) AU700019B2 (de)
BR (1) BR9307401A (de)
CA (1) CA2148795C (de)
CY (1) CY2231B1 (de)
CZ (1) CZ117395A3 (de)
DE (1) DE69328438T2 (de)
DK (1) DK0668769T3 (de)
ES (1) ES2147780T3 (de)
HU (1) HUT73791A (de)
MX (1) MX9306960A (de)
NO (1) NO951740L (de)
NZ (1) NZ258019A (de)
OA (1) OA10153A (de)
PL (1) PL308770A1 (de)
PT (1) PT668769E (de)
WO (1) WO1994011010A2 (de)
ZA (1) ZA938274B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014870B1 (en) * 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
US20040037898A1 (en) * 1997-10-08 2004-02-26 Hon David N.S Compositions of oak bark extract, related synthetic compositions and method of using same
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
US20040170703A1 (en) * 2001-11-29 2004-09-02 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
AU2002359529B2 (en) * 2001-11-29 2008-02-21 Greystone Medical Group, Inc. Treatment of wounds and compositions employed
US6667026B1 (en) 2002-03-15 2003-12-23 Pocono Falls, Inc. Allergic contact dermatitis treatment and composition therefor
JP2005527613A (ja) * 2002-05-24 2005-09-15 グレイストーン メディカル グループ、インコーポレイテッド 抗癌製剤
JP2006511585A (ja) * 2002-12-23 2006-04-06 グレイストーン メディカル グループ、インコーポレイテッド 慢性創傷管理における活性酸素種の減少
WO2005000328A1 (en) * 2003-06-24 2005-01-06 Zanti Gianfranco Compositions based on plant ash for the treatment of skin diseases
JP2008503592A (ja) * 2004-06-22 2008-02-07 グレイストーン メディカル グループ、インコーポレイテッド 徐放性組成物を用いた創傷の治療方法
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
WO2007089267A1 (en) 2006-02-03 2007-08-09 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
CA2700990C (en) 2007-03-15 2014-08-12 Om Kataria Uterine stimulant sticks
ES2652114T3 (es) 2007-10-15 2018-01-31 7 Oaks Pharmaceutical Corporation Una disolución que contiene silicato para uso en el tratamiento de melanoma
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
WO2011103158A1 (en) * 2010-02-16 2011-08-25 Michael Darryl Black Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US8828449B2 (en) 2012-01-26 2014-09-09 Libby Robinson Wound dressing composition and method of use
US9351995B1 (en) 2011-04-29 2016-05-31 Red Oax Holdings, LLC Compositions and methods of enhancing wound healing
JP2014520657A (ja) * 2011-07-20 2014-08-25 スリーエム イノベイティブ プロパティズ カンパニー イオン担持組成物を含んだ包帯
EP2736486B1 (de) * 2011-07-28 2019-03-06 3M Innovative Properties Company Wundheilende zusammensetzungen und verwendungsverfahren dafür
CN103732192B (zh) 2011-08-17 2016-03-16 3M创新有限公司 单体接枝纤维及其用途
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
US10500235B2 (en) 2015-01-29 2019-12-10 San Melix Laboratories, Inc. Wound healing compositions comprising buckwheat honey and methylglyoxal and methods of use
BR112021017547A2 (pt) * 2019-03-04 2021-11-09 Celloryx AG Bactéria recombinante, ácido nucleico recombinante, dispositivo médico, composição farmacêutica, kit para uso em medicina e uso de um meio de reconstituição
IT201900018047A1 (it) * 2019-10-07 2021-04-07 Nello Vallicella Procedimento per la preparazione di una composizione topica liquida.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US256847A (en) * 1882-04-25 Salve
US37901A (en) * 1863-03-17 Improved liniment
US55911A (en) * 1866-06-26 Improved medical compound
US202246A (en) * 1878-04-09 Improvement in medical compounds
DE819127C (de) * 1949-09-28 1951-10-29 Heinz Dr Bauer Verfahren zur Herstellung eines Heilbades gegen Hautekzeme
DE812341C (de) * 1950-03-07 1951-08-27 Penicillin Ges Dauelsberg & Co Verfahren zur Herstellung eines Hautbehandlungsmittels
DE833840C (de) * 1950-06-01 1952-03-13 Dr Heinz Bauer Verfahren zur Herstellung einer Salbe gegen Hautekzeme
US3928584A (en) * 1969-06-30 1975-12-23 Us Health Education & Welfare Extracts from active tree saps for treating P388 mouse leukemia
US4059695A (en) * 1974-02-14 1977-11-22 Kanari Hirosaki Method for manufacturing a tonic composition for man and other animals
JPS60164467A (ja) * 1984-02-07 1985-08-27 Rooman Kogyo:Kk 飲料
ATE69954T1 (de) * 1985-10-08 1991-12-15 Psori Med Ag Salzmischung zur behandlung der schuppenflechte (psoriasis) und anderer hautkrankheiten.
US4847083A (en) * 1986-04-02 1989-07-11 Dermasciences, Inc. Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
BE1000950A3 (fr) * 1987-10-05 1989-05-23 Claude Patricia Produit de beaute saliaris au sel de la mer morte et a l'argile verte de haute provence.
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
US5080900A (en) * 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash

Also Published As

Publication number Publication date
AU5550094A (en) 1994-06-08
CZ117395A3 (en) 1995-11-15
CA2148795A1 (en) 1994-05-26
DK0668769T3 (da) 2000-10-02
NO951740L (no) 1995-06-19
EP0668769B1 (de) 2000-04-19
US6149947A (en) 2000-11-21
PT668769E (pt) 2000-10-31
NO951740D0 (no) 1995-05-04
EP0668769A1 (de) 1995-08-30
DE69328438T2 (de) 2001-01-04
PL308770A1 (en) 1995-08-21
HU9501323D0 (en) 1996-05-28
WO1994011010A2 (en) 1994-05-26
CY2231B1 (en) 2003-04-18
HUT73791A (en) 1996-09-30
OA10153A (en) 1996-12-18
WO1994011010A3 (en) 1994-09-15
ATE191850T1 (de) 2000-05-15
BR9307401A (pt) 1999-08-24
JP3640215B2 (ja) 2005-04-20
ZA938274B (en) 1994-06-09
AU700019B2 (en) 1998-12-17
NZ258019A (en) 1998-12-23
MX9306960A (es) 1995-01-31
CA2148795C (en) 2004-08-10
ES2147780T3 (es) 2000-10-01
JPH08503462A (ja) 1996-04-16

Similar Documents

Publication Publication Date Title
DE69328438D1 (de) Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
ES2052871T3 (es) Preparacion de bis (3,5-di-t-butil-4-hidroxifeniltio)metano.
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
ATE233558T1 (de) Verwendung von strontiumsälze zur behandlung von arthrose
ES2033434T3 (es) Composicion cosmetica.
WO1994011010B1 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
AU6998787A (en) Transglutaminase inhibitors
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
ATE225340T1 (de) Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
ATE42466T1 (de) Verwendung von saccharomyces hefen zur herstellung eines medikaments zur verhuetung oder behandlung von pseudomembrankolitis.
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE69232852D1 (de) Verwendung von topotecan in der behandlung von nichtkleinzelligen lungenkarzinomen
IT1199960B (it) Agenti stimolanti la crescita dei capelli e loro impiego
ATE77952T1 (de) Verwendung von 1,4-dihydropyridinderivaten.
MX9405923A (es) Mejoras en proceso para humectar y suavizar la piel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: HARWARDT NEUMANN MUELLER & PARTNER PATENTANWAELTE, 5